Fingerprint
Dive into the research topics of 'Persistent CD-19 depletion by rituximab is cost-effective in maintaining remission in calcineurin-inhibitor dependent podocytopathy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically